Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-25T08:58:45.635Z Has data issue: false hasContentIssue false

A Controlled Comparison of Flupenthixol Decanoate Injections and Oral Amitriptyline in Depressed Out-Patients

Published online by Cambridge University Press:  29 January 2018

W. Tam
Affiliation:
University of Hong Kong; formerly Clinical Research Assistant, Department of Pharmacology, Institute of Psychiatry
J. P. R. Young
Affiliation:
St Thomas's Hospital, London
G. John
Affiliation:
Stone House Hospital, Dartford, Kent; St Thomas's Hospital
M. H. Lader
Affiliation:
Institute of Psychiatry, De Crespigny Park, London SE5

Summary

Sixty-eight depressed out-patients were allocated to treatment with either oral amitriptyline (75–225 mg/day) or intramuscular flupenthixol decanoate (10–30 mg every 14 days) in flexible dosage for 12 weeks under double-blind procedures. Various observer- and self-rating scales were applied before and after 2, 4, 8 and 12 weeks of treatment. Twenty-four patients completed the course of amitriptyline and 20 the course of flupenthixol. All variables improved over time, but there were no significant differences between the two drugs. The Newcastle scores pre-treatment were not related to drug response suggesting that both drugs were similarly effective across a wide spectrum of depressive disorders. Patients on amitriptyline tended to complain of dry mouth; those on flupenthixol had a higher incidence of extrapyramidal signs, the majority receiving anti-parkinsonian drugs at some time during the treatment. Flupenthixol decanoate in low dose is a useful anti-depressant, but should be restricted to short courses of treatment, to patients refractory to other treatments, and to patients suspected of poor compliance.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Frolund, F. (1974) A controlled trial of flupenthixol. Current Medical Research and Opinion, 2, 7889.Google Scholar
Holst, B. (1965) N 7009 in the treatment of anxiety states. Acta Psychiatrica Scandinavica, Supplement No. 180, 415–8.Google Scholar
Johnson, D. A. W. (1973) Treatment of depression in general practice. British Medical Journal, ii, 1820.CrossRefGoogle Scholar
Johnson, D. A. W. (1979) A double-blind comparison of flupenthixol, nortriptyline and diazepam in neurotic depression. Acta Psychiatrica Scandinavica, 59, 18.Google Scholar
J⊘rgensen, A. (1980) Pharmacokinetic studies in volunteers of intravenous and oral cis (Z)-flupenthixol and intramuscular cis (Z)-flupenthixol decanoate in Viscoleo®. European Journal of Clinical Pharmacology, 18, 16.Google Scholar
Merskey, H. (1971) Flupenthixol (Fluanxol). British Journal of Psychiatry, 119, 230.Google Scholar
Ovhed, I. (1976) A double-blind study of flupenthixol (Fluanxol) in general practice. Current Medical Research and Opinion, 4, 144–50.Google Scholar
Predescu, V., Ciurezy, T., Timofte, G. & Roman, I. (1973) Symptomatic relief with flupenthixol (Fluanxol) of the anxious algetic-depressive syndrome complex in neurotic states. Acta Psychiatrica Scandinavica, 49, 1527.Google Scholar
Rama Rao, V. A., Bishop, M. & Coppen, A. (1980) Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia. British Journal of Psychiatry, 137, 518–21.Google Scholar
Reiter, P. (1969) On flupenthixol, an antidepressant of a new chemical group. British Journal of Psychiatry, 115, 1399–402.Google Scholar
Sonne, L. M. (1966) Behandling af depressive tilstande med flupentixol. Nordisk Psychiatrisk Tiddskrtft, 20, 322–4.Google Scholar
Wilcox, D. R. C., Gillan, R. & Hare, E. H. (1965) Do psychiatric outpatients take their drugs? British Medical Journal, ii, 790.CrossRefGoogle Scholar
Young, J. P. R., Hughes, W. C. & Lader, M. H. (1976) A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. British Medical Journal i, 1116–8.Google Scholar
Young, J. P. R., Lader, M. H. & Hughes, W. C. (1979) Controlled trial of trimipramine, monoamine oxidase inhibitors, and combined treatment in depressed outpatients. British Medical Journal, ii, 1315–17.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.